BM

Bhavya Mishra

Active Director Designated Partner DIN 10002528
DIN 10002528 First appointment May 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhavya Mishra

Data last updated:

Bhavya Mishra is a Designated Partner at Durosine Pharmaceuticals Llp (since 2022). The company operates in Business Services.

DIN 10002528
Primary Designation Designated Partner
Industry Business Services
First Appointment 20 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 May 20222022Active

Board colleagues of Bhavya Mishra

NameDINCompanyDesignation
Abhai Kumar Mishra01519792Durosine Pharmaceuticals LlpDesignated Partner
Ajeet Kumar Pandey10049554Durosine Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Durosine Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Bhavya Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhavya Mishra

Bhavya Mishra currently holds 1 directorship: Durosine Pharmaceuticals Llp (Designated Partner, since 20 May 2022).

Bhavya Mishra was first appointed on 20 May 2022 as Designated Partner at Durosine Pharmaceuticals Llp.

The current boards of Bhavya Mishra's companies include Abhai Kumar Mishra (Durosine Pharmaceuticals Llp), Ajeet Kumar Pandey (Durosine Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available